Ginkgo Bioworks DNA Convertible Preferred Stock Authorized Shares
Convertible Preferred Stock Authorized Shares at other companies
Other financials
Where this comes from
Reported directly by Ginkgo Bioworks in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.
The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ginkgo Bioworks's convertible preferred stock authorized shares.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ginkgo Bioworks's convertible preferred stock authorized shares?
- Ginkgo Bioworks (DNA) reported convertible preferred stock authorized shares of 200M in Q1 2026.
- How has Ginkgo Bioworks's convertible preferred stock authorized shares changed year-over-year?
- Ginkgo Bioworks's convertible preferred stock authorized shares decreased by 0.0% year-over-year, from 200M to 200M.
- What is the long-term trend for Ginkgo Bioworks's convertible preferred stock authorized shares?
- Over 5 years (2020 to 2025), Ginkgo Bioworks's convertible preferred stock authorized shares has grown at a 0.0% compound annual growth rate (CAGR), from 200M to 200M.
- What does convertible preferred stock authorized shares mean?
- Maximum number of convertible preferred shares the company is authorized to issue under its corporate charter.